Home Cart Sign in  
Chemical Structure| 202189-78-4 Chemical Structure| 202189-78-4

Structure of Bilastine
CAS No.: 202189-78-4

Chemical Structure| 202189-78-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Bilastine selectively antagonizes histamine H1 receptor and it is used to treat allergic rhinoconjunctivitis and urticaria.

Synonyms: F-96221-BM1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Bilastine

CAS No. :202189-78-4
Formula : C28H37N3O3
M.W : 463.61
SMILES Code : O=C(O)C(C)(C)C1=CC=C(CCN2CCC(C3=NC4=CC=CC=C4N3CCOCC)CC2)C=C1
Synonyms :
F-96221-BM1
MDL No. :MFCD09837814
InChI Key :ACCMWZWAEFYUGZ-UHFFFAOYSA-N
Pubchem ID :185460

Safety of Bilastine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Bilastine

GPCR

Isoform Comparison

Biological Activity

Target
  • H1 receptor

    H1 receptor, Ki:44.15 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02557269 Seasonal Allergic Rhinitis Phase 4 Unknown December 2015 Bulgaria ... More >> Medical University Sofia, University Hospital "Alexandrovska", Clinic of Allergy and Asthma Sofia, Bulgaria, 1431 Less <<
NCT01940393 Urticaria Phase 4 Completed - Colombia ... More >> Medellin Medellin, Antioquia, Colombia Less <<
NCT00421109 Urticaria Phase 3 Completed - -
NCT00419783 Healthy Phase 1 Completed - United States, Arizona ... More >> MDS Pharma Services Phoenix, Arizona, United States, 85044 Less <<
NCT00504933 Seasonal Allergic Rhinitis Phase 3 Completed - -
NCT00420082 Seasonal Allergic Rhinitis Phase 2 Completed - Austria ... More >> Allergy Center Vienna West Vienna, Austria, A-1150 Less <<
NCT01108783 Seasonal Allergic Rhinitis Phase 3 Completed - -
NCT01127620 Perennial Allergic Rhinitis Phase 3 Completed - -
NCT00574210 Seasonal Allergic Rhinitis ... More >> Hay Fever Rhinoconjunctivitis Less << Phase 2 Completed - Canada, Ontario ... More >> Allied Research International - Cetero Research Mississauga, Ontario, Canada, 905-238-0599 Less <<
NCT01400828 Seasonal Allergic Rhinitis Phase 3 Completed - Korea, Republic of ... More >> Yonsei University college of Medicine, Gangnam Severance Hospital Seoul, Korea, Republic of Less <<
NCT00574379 Seasonal Allergic Rhinitis ... More >> Hay Fever Allergic Conjunctivitis Hypersensitivity Less << Phase 2 Completed - United States, Oklahoma ... More >> Oklahoma Allergy and Asthma Clinic Oklahoma City, Oklahoma, United States, 73104 United States, Texas MetaClin Research Inc. Austin, Texas, United States, 78704 Austin Clinical Research Austin, Texas, United States, 78750 Lovelace Scientific Resources Austin, Texas, United States, 78759 Kerrville Research Associates Kerrville, Texas, United States, 78028-6071 Biogenics Research Institute San Antonio, Texas, United States, 78229 DGD Research San Antonio, Texas, United States, 78229 Diagnostics Research Group San Antonio, Texas, United States, 78229 Southwest Allergy and Asthma Centre San Antonio, Texas, United States, 78229 Sylvana Research Associates San Antonio, Texas, United States, 78229 Live Oak Allergy and Asthma San Antonio, Texas, United States, 78233 Allergy & Asthma Care of Waco Waco, Texas, United States, 76708 Allergy Asthma Research Institute Waco, Texas, United States, 76712 Less <<
NCT03479307 Allergic Conjunctivitis Phase 3 Completed - United States, Arizona ... More >> Cornea Consultants of AZ Phoenix, Arizona, United States, 85032 United States, California East West Eye Institute Torrance, California, United States, 90505 United States, Massachusetts Andover Eye Associates Andover, Massachusetts, United States, 01810 United States, Ohio Apex Eye Mason, Ohio, United States, 45040 United States, Pennsylvania Philadelphia Eye Associates Philadelphia, Pennsylvania, United States, 19134 United States, Tennessee Total Eye Care, P.A. Memphis, Tennessee, United States, 38119 Less <<
NCT03231969 Allergic Conjunctivitis Phase 2 Completed - United States, Massachusetts ... More >> Ora Clinical Research Center Andover, Massachusetts, United States, 01810 Less <<
NCT00572611 Healthy Phase 1 Completed - United Kingdom ... More >> Charles River Laboratories Clinical Services Ltd, Origo Centre Riccarton, Edinburgh, United Kingdom, EH14 4AP Less <<
NCT02213367 Chronic Urticaria Phase 3 Completed - Germany ... More >> Dpt. of Dermatology and Allergy Berlin, Germany, 10117 Less <<
NCT02576041 Allergic Rhinitis ... More >> Urticaria Less << Phase 4 Completed - Italy ... More >> Azienda Ospedaliero-Universitaria Policlinico Modena, Italy Less <<
NCT02576041 - Completed - -
NCT01081574 Allergic Rhinoconjunctivitis|C... More >>hronic Urticaria Less << PHASE1|PHASE2 COMPLETED 2025-06-12 Royal Children's Hospital, Par... More >>kville, Victoria, 3052, Australia|Princess Margaret Hospital for Children, Subiaco, Western Australia, 6840, Australia|Charité - Universit?tsmedizin. Campus Virchow-Klinikum. Klinik für P?diatrie mit Schwerpunkt Pneumologie/Immunologie, Berlin, 13353, Germany|Klinikum der Johann-Wolfgang-Goethe-Universit?t Frankfurt, Franfurt, 60590, Germany|Universit?ts-Hautklinik, Kiel, 24105, Germany|Karolinska University Hospital. Astrid Lindgren's Hospital, Stockholm, 17176, Sweden|Children's Hospital at Uppsala University Hospital, Uppsala, 751 85, Sweden Less <<
NCT01124123 Healthy Phase 1 Completed - Spain ... More >> Unidad de Investigacion Clinica. Clinica Universidad de Navarra Pamplona, Navarra, Spain, 31008 Less <<
NCT03633760 Pharmacokinetics Phase 1 Recruiting January 31, 2019 China, Hong Kong ... More >> Phase I Clinical Trial Centre, Chinese University of Hong Kong Recruiting Hong Kong, Hong Kong, China, 999077 Contact: Andrea Luk, Professor Less <<
NCT02761252 Seasonal Allergic Rhinoconjunc... More >>tivitis Asthma Less << Phase 4 Completed - Croatia ... More >> Cakovec, Croatia Rijeka, Croatia Zagreb, Croatia Czechia Brno, Czechia Ostrava Hrabuvka, Czechia Teplice, Czechia Germany Dreieich, Germany Heidelberg, Germany Weisbaden, Germany Italy Catania, Italy Florence, Italy Modena, Italy Pavia, Italy Verona, Italy Latvia Riga, Latvia Poland Bialystok, Poland Bielsko-Biala, Poland Gdansk, Poland Katowice, Poland Krakow, Poland Lodz, Poland Lublin, Poland Nowy Duninow, Poland Poznan, Poland Rzeszow, Poland Tarnow, Poland Wroclaw, Poland Romania Brasov, Romania Bucharest, Romania Cluj Napoca, Romania Ploieşti, Romania Slovakia Bardejov, Slovakia Levice, Slovakia Less <<
NCT02513290 Allergic Rhinitis Phase 4 Completed - -
NCT01271075 Cold Contact Urticaria Phase 2 Phase 3 Completed - Germany ... More >> Charité-Universitätsmedizin Berlin Berlin, Germany, 10117 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.16mL

0.43mL

0.22mL

10.78mL

2.16mL

1.08mL

21.57mL

4.31mL

2.16mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories